Table 1

Sociodemographic and neurological details of 43 patients included in the study

*No patient was diagnosed with SMS and myoclonus (jerking SMS6).
AMP, amphiphysin; GAD, glutamic acid decarboxylase; PERM, progressive encephalomyelitis with rigidity and myoclonus; pSMS, paraneoplastic stiff man syndrome; SLS, stiff leg syndrome; SMS, stiff man syndrome.
Total number43
    Male (n (%))14 (32.6)
    Female (n (%))29 (67.4)
Age (years)
    Range18 to 75
    Mean (SD)52.9 (13.8)
Duration of disease (years)
    Range0.5 to 35
    Mean (SD)7.8 (7.5)
Type of disease* (n (%))
    SMS22 (51.2)
    PERM15 (34.9)
    SLS3 (7.0)
    pSMS3 (7.0)
Antibody status (n (%))
    AntiGAD positive30 (69.8)
    AntiAMP positive2 (4.7)
    AntiGAD/AMP negative11 (25.6)
Task specific phobia (n (%))
    Present19 (44.2)
    Phobic anxiety w/o avoidance3 (7.0)
    Absent21 (48.8)